Metraipolis › archive › dc_7fb537fb61ce

Targeted next-generation sequencing implementation in Eswatini identifies rifampicin and bedaquiline resistance undetected by routine diagnostic testing — Europe PMC PMID:42270607

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42270607
DOI: 10.1038/s41467-[numero omesso]-w
License (as archived): solo-consultazione
Archived: 2026-10-31T14:15:47.638Z
SHA-256 of the archived text: 0850a7b1c22fae45d03de736f6ef572eb2575083342840a690d7af9acea1c53c
Stable URL of this page: https://metraipolis.com/documento/dc_7fb537fb61ce

How to cite

Targeted next-generation sequencing implementation in Eswatini identifies rifampicin and bedaquiline resistance undetected by routine diagnostic testing — Europe PMC PMID:42270607 — Europe PMC (en), https://europepmc.org/article/MED/42270607 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7fb537fb61ce (Metraipolis archive dc_7fb537fb61ce, sha256 0850a7b1c22fae45d03de736f6ef572eb2575083342840a690d7af9acea1c53c)

BibTeX

@misc{dc7fb537fb61ce,
  title = {Targeted next-generation sequencing implementation in Eswatini identifies rifampicin and bedaquiline resistance undetected by routine diagnostic testing — Europe PMC PMID:42270607},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42270607},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7fb537fb61ce; sha256 0850a7b1c22fae45d03de736f6ef572eb2575083342840a690d7af9acea1c53c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42270607. Agents can read the archived copy with the MCP tool read_document.